A clinical trial to see the efficacy of angamardaprashamana ghanavati in patients with chronic fatigue syndrome and repetitive stress injury

A conceptual and applied study on angamardaprashamana mahakashaya vis-a-vis chronic fatigue syndrome and repetitive stress injury

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031222

Enrollment

Registered

2021-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: ANGAMARDAPRASHAMANA GANAVATI: â?¢Drug: Angamardaprashmana dashemani dravyas of Charaka samhita

viz Vidariganda, Prishnaparni, Brihati, Kantakarika, Eranda, Kakoli, Chandana, Ushira, Ela & Madhuka

all drugs taken in equal quantity. â?¢Form: Ganavati kalpana â?¢Mode of Administration: Orally â?¢Dose: 3grams a day in divided doses

2 vatiâ??s of 500 mg thrice a day, after food â?¢Anupana: Hot water â?¢Duration: 24 days (Ardha Mandala). Intervention2: Angamardaprashamana mahakashaya ghanavati: Drugs: vidariganda, prushnaparni,

Eligibility

Inclusion criteria

Inclusion criteria: Chronic fatigue syndrome 1. Subjects presenting with classical features of Chronic fatigue syndrome & fulfilling diagnostic criteria. Repetitive stress injury 1. Subjects using computer >40 hours/ week (Approx.5-6 hours/day) 2. Stage III Repetitive stress injury 3. subjects fulfilling diagnostic criteria. 4. Subjects willing to participate.

Exclusion criteria

Exclusion criteria: Chronic fatigue syndrome 1. Subjects having any other medical condition explaining fatigue 2. Major depressive disorders (psychotic features) or bipolar disorders. 3. Schizophrenia, dementia or delusional disorders 4. Anorexia nervosa, bulimia nervosa 5. Alcohol or substance abuse 6. Severe obesity (BMI >40) Repetitive stress injury 1. Any H/O upperlimb fracture 2. Any H/O pathological disorders of upperlimb 3. All regular exercise 4. Subjects with Congenital anomalies

Design outcomes

Primary

Measure	Time frame
Reduction in the signs and symptoms of chronic fatigue syndrome and Repetitive stress injuryTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Nature and presentation of the disease can be knownTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Kavya K

Government Ayurveda Medical College and Hospital, Mysuru

dr.shreevathsa@rediffmail.com9449772701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026